Literature DB >> 11354640

SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens.

C F Rochette1, N Gilbert, L R Simard.   

Abstract

The spinal muscular atrophy (SMA) region on chromosome 5q13 contains an inverted duplication of about 500 kb, and deleterious mutations in the survival motor neuron 1 (SMN1) gene cause SMA, a common lethal childhood neuropathy. We have used a number of approaches to probe the evolutionary history of these genes and show that SMN gene duplication and the appearance of SMN2 occurred at very distinct evolutionary times. Molecular fossil and molecular clock data suggest that this duplication may have occurred as recently as 3 million years ago in that the position and identity repetitive elements are identical for both human SMN genes and overall sequence divergence ranged from 0.15% to 0.34%. However, these approaches ignore the possibility of sequence homogenization by means of gene conversion. Consequently, we have used quantitative polymerase chain rection and analysis of allelic variants to provide physical evidence for or against SMN gene duplication in the chimpanzee, mankind's closest relative. These studies have revealed that chimpanzees have 2-7 copies of the SMN gene per diploid genome; however, the two nucleotides diagnostic for exons 7-8 and the SMNdelta7 mRNA product of the SMN2 gene are absent in non-human primates. In contrast, the SMN2 gene has been detected in all extant human populations studied to date, including representatives from Europe, the Central African Republic, and the Congo. These data provide conclusive evidence that SMN gene duplication occurred more than 5 million years ago, before the separation of human and chimpanzee lineages, but that SMN2 appears for the first time in Homo sapiens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354640     DOI: 10.1007/s004390100473

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  76 in total

1.  Molecular characterization of the pericentric inversion that causes differences between chimpanzee chromosome 19 and human chromosome 17.

Authors:  Hildegard Kehrer-Sawatzki; Bettina Schreiner; Simone Tänzer; Matthias Platzer; Stefan Müller; Horst Hameister
Journal:  Am J Hum Genet       Date:  2002-07-01       Impact factor: 11.025

2.  Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients.

Authors:  Miloš Brkušanin; Ana Kosać; Vladimir Jovanović; Jovan Pešović; Goran Brajušković; Nikola Dimitrijević; Slobodanka Todorović; Stanka Romac; Vedrana Milić Rašić; Dušanka Savić-Pavićević
Journal:  J Hum Genet       Date:  2015-08-27       Impact factor: 3.172

3.  Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.

Authors:  Natalia N Singh; Brian M Lee; Ravindra N Singh
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

4.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

5.  Quantification of PCR bias caused by a single nucleotide polymorphism in SMN gene dosage analysis.

Authors:  Shuji Ogino; Robert B Wilson
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

6.  An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival.

Authors:  John C Fyfe; Marilyn Menotti-Raymond; Victor A David; Lars Brichta; Alejandro A Schäffer; Richa Agarwala; William J Murphy; William J Wedemeyer; Brittany L Gregory; Bethany G Buzzell; Meghan C Drummond; Brunhilde Wirth; Stephen J O'Brien
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

7.  Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.

Authors:  Tristan H Coady; Christian L Lorson
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

8.  WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.

Authors:  Salah Mahmoudi; Sofia Henriksson; Irene Weibrecht; Stephen Smith; Ola Söderberg; Staffan Strömblad; Klas G Wiman; Marianne Farnebo
Journal:  PLoS Biol       Date:  2010-11-02       Impact factor: 8.029

Review 9.  Spinal muscular atrophy: journeying from bench to bedside.

Authors:  Tomoyuki Awano; Jeong-Ki Kim; Umrao R Monani
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

10.  Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA.

Authors:  Virginia B Mattis; Marina Y Fosso; Cheng-Wei Chang; Christian L Lorson
Journal:  BMC Neurosci       Date:  2009-11-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.